Treatment Course of Patients with Exudative Age-Related Macular Degeneration Using Ocular Hypotensives.

Bobeck S ModjtahediTiffany Q LuongStephan ChiuTavé van ZylJane C LinDonald S Fong

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

Patients with concurrent glaucoma and exudative AMD have similar visual outcomes and treatment courses compared to those not taking ocular hypotensives. Although aqueous suppressants have been suggested to prolong anti-VEGF residence time, patients using these agents did not demonstrate visual benefit or a reduced injection burden in this series.

Keyphrases

age related macular degeneration
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
type diabetes
endothelial cells
metabolic syndrome
vascular endothelial growth factor
ionic liquid
locally advanced
rectal cancer